Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VHL | P40337 | 6/20 | 0.53 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.42 |
| ▸ | CCNE1 | P24864 | 10/20 | 0.41 |
| ▸ | CDK2 | P24941 | 10/20 | 0.41 |
| ▸ | GSK3B | P49841 | 7/20 | 0.41 |
| ▸ | ELOC | Q15369 | 3/20 | 0.40 |
| ▸ | ELOB | Q15370 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20012510 | 0.85 | VHL (0.51) | VHLP2RX7CCNE1CDK2GSK3B | |
| SCHEMBL20008980 | 0.84 | VHL (0.50) | VHLP2RX7CCNE1CDK2GSK3B | |
| SCHEMBL21696556 | 0.82 | CCNE1 (0.54) | VHLCCNE1CDK2GSK3B | |
| SCHEMBL21696439 | 0.82 | CCNE1 (0.54) | VHLCCNE1CDK2GSK3B | |
| SCHEMBL21696706 | 0.80 | CCNE1 (0.54) | VHLCCNE1CDK2GSK3BNPC1 | |
| SCHEMBL15112607 | 0.74 | VHL (0.55) | VHLP2RX7CCNE1CDK2GSK3B | |
| SCHEMBL32661830 | 0.73 | VHL (0.51) | VHLP2RX7CCNE1CDK2GSK3B | |
| SCHEMBL21696674 | 0.72 | VHL (0.50) | VHLP2RX7CCNE1CDK2GSK3B | |
| SCHEMBL15126220 | 0.72 | VHL (0.53) | VHLP2RX7CCNE1CDK2GSK3B | |
| SCHEMBL26243988 | 0.72 | P2RX7 (0.41) | VHLP2RX7CCNE1CDK2GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3262036-B1 | THERAPEUTIC PYRIDAZINE COMPOUNDS AND USES THEREOF | GENENTECH INC (US) | 2023-09-13 | — | — | EP | disclosed |